U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. U.F.S. Industries, Inc. d.b.a. Sally Sherman Foods - 580946 - 03/31/2021
  1. Warning Letters

CLOSEOUT LETTER

U.F.S. Industries, Inc. d.b.a. Sally Sherman Foods MARCS-CMS 580946 —

Delivery Method:
VIA UNITED PARCEL SERVICE
Product:
Food & Beverages
Recipient:
Recipient Name
Mr. Felix Endico/Mr. William Endico
Recipient Title
Owner
U.F.S. Industries, Inc. d.b.a. Sally Sherman Foods

300 N. MacQuesten Pkwy
Mount Vernon, NY 10550-1008
United States

Issuing Office:
Office of Human and Animal Food Operations East Division 1

United States

Dear Messrs. Endico:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter CMS# 580946, issued on July 30, 2019. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
CDR Catherine Beer
Director, Compliance Branch
Office of Human and Animal Food Operations East Division 1

Back to Top